IBUPROFEN LYSINE Drug Patent Profile
✉ Email this page to a colleague
When do Ibuprofen Lysine patents expire, and what generic alternatives are available?
Ibuprofen Lysine is a drug marketed by Xgen Pharms and is included in one NDA.
The generic ingredient in IBUPROFEN LYSINE is ibuprofen lysine. There are sixty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibuprofen lysine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ibuprofen Lysine
A generic version of IBUPROFEN LYSINE was approved as ibuprofen lysine by XGEN PHARMS on March 30th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN LYSINE?
- What are the global sales for IBUPROFEN LYSINE?
- What is Average Wholesale Price for IBUPROFEN LYSINE?
Summary for IBUPROFEN LYSINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 5 |
| Patent Applications: | 207 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for IBUPROFEN LYSINE |
| What excipients (inactive ingredients) are in IBUPROFEN LYSINE? | IBUPROFEN LYSINE excipients list |
| DailyMed Link: | IBUPROFEN LYSINE at DailyMed |
Recent Clinical Trials for IBUPROFEN LYSINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Oxford Pharmascience Ltd | Phase 1 |
| Simbec Research | Phase 1 |
| Reckitt Benckiser Healthcare (UK) Limited | Phase 1 |
Pharmacology for IBUPROFEN LYSINE
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for IBUPROFEN LYSINE
Paragraph IV (Patent) Challenges for IBUPROFEN LYSINE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| NEOPROFEN | Injection | ibuprofen lysine | 10 mg/mL, 2 mL vials | 021903 | 1 | 2010-10-01 |
US Patents and Regulatory Information for IBUPROFEN LYSINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xgen Pharms | IBUPROFEN LYSINE | ibuprofen lysine | INJECTABLE;INTRAVENOUS | 202402-001 | Mar 30, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
